Ellevest Inc’s Histogen Inc. Common Stock HSTO Stock Holding History

Ellevest Inc’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	1725
2021 Q4	$0	Buy	+1	New	+$11	﹤0.01%	1760

Other funds holding HSTO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Ellevest Inc's HSTO Position: Q1 2022 in Review

Ellevest Inc sold out of Histogen Inc. Common Stock (HSTO) in Q1 2022, closing a stake of 1 share.

Ellevest Inc first reported a position in HSTO in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 22 funds tracked by Wall St. Rank hold HSTO as of Q1 2022.

Ellevest Inc reported no remaining Histogen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Ellevest Inc sold 1 Histogen Inc. Common Stock share in Q1 2022.
Ellevest Inc first reported a position in Histogen Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Ellevest Inc's Histogen Inc. Common Stock position peaked at $0 in Q4 2021.
22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2022.

Based on Ellevest Inc's 13F filing for Q1 2022, filed 19 Apr 2022.